Donald Trump’s tariff tussle: Duties on Indian pharma would be ‘counterproductive’; America may take at least 3 years to match India’s scale, says Pharmexcil
US President Donald Trump imposed an additional 25% tariff on Indian imports on the top of an already existing 25% duty, pushing the total to 50%. These high tariffs, announced on August 6, would take effect from August 27.The pharmaceutical sector, however, received a temporary exemption from the tariff hike, highlighting India’s crucial role in…

